• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17988 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Holmium laser enucleation in benign prostatic hyperplasia]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Human dermal allograft for massive rotator cuff tears
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [No-scalpel versus conventional vasectomy]
2019     NIHR Health Services and Delivery Research programme PRESENT: Patient Reported Experience Survey Engineering of Natural Text: developing practical automated analysis and dashboard representations of cancer survey freetext answers
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) 177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate
2019     National Committee for Technology Incorporation (CONITEC) [Diagnostic tests for thrombophilia in pregnancy]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Quantitative electroencephalography]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Reiki therapy in anxiety, depression and pain]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Hip arthroscopy for painful hip treatment]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Irreversible electroporation for the treatment of liver and pancreatic cancer
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Prostate rectum spacing in prostate radiation therapy]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Endovascular thrombectomy in acute ischemic stroke]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for Diabetes mellitus: guideline recommendations
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Deep anterior lamellar keratoplasty in keratoconus]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Public & philanthropic financial contribution to the development of new drugs: Methodology & 3 Case Studies
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Shoulder prosthesis in complex proximal humeral fractures]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) FoundationOne®CDx: genetic profiling of solid tumours
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Implantable cardiac monitors in syncope of unknown etiology]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Rapid on-site evaluations of cytological punctures]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Per-oral endoscopic myotomy (POEM) in achalasia]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pharma: Disclosure of transfers of value in Austria 2018. Update of the systematic analysis 2015
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Optical coherence tomography: usefulness in glaucoma, diabetic retinopathy and age-related macular degeneration]
2019     NIHR Health Technology Assessment programme Cabozantinib and vandatinib for treating advanced or metastatic medullary thyroid cancer (ID56)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) as first-line therapy for PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (NSCLC)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Video head impulse test in vertigo]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Palivizumab for the prevention of respiratory syncytial virus lower respiratory tract infections]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Sacral nerve stimulation/neuromodulation in bladder and/or bowel incontinence]
2019     NIHR Health Technology Assessment programme An evaluation of the feasibility of conducting a randomised clinical trial to evaluate the clinical and cost-effectiveness of a more permissive temperature threshold for antipyretic intervention in critically ill children with fever due to infection: the FEVER feasibility study
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cervical Carcinoma Prevention - Implementation of an HPV screening test for early detection of cervical cancer in Austria
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge, state of practice: Use of direct oral anticoagulants and warfarin in the context of atrial fibrillation and venous thromboembolism]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Eposterior tibial nerve stimulation in overactive bladder and bowel incontinence]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) POCT/ Point of Care Tests: D-Dimer and Troponin
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: anticoagulant therapy]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Pelvic vein embolization or sclerotherapy in pelvic congestion syndrome]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Minimum volume standards for quality assurance in day surgery: Fundamentals and Systematic Review
2019     Center for Evidence-based Practice (CEP) Pulmonary Artery Catheters Catheter Dwell Time and Routine Replacement
2019     Center for Evidence-based Practice (CEP) Dual Antiplatelet Therapy Following Revascularization for Peripheral Artery Disease
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Lenvatinib for iodine-refractory differentiated thyroid cancer]
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Irreversible electroporation for the treatment of liver and pancreatic cancer]
2019     Center for Evidence-based Practice (CEP) Dosing of Botulinum Toxin for Neurologic Indications
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Diagnostic accuracy and clinical utility of PET/CT amyloid in mild cognitive impairment
2019     Andalusian Health Technology Assessment Area (AETSA) Genetic diseases in Spain. Map of genetic test available in the National Health System. Upgrade.
2019     Center for Evidence-based Practice (CEP) Management of Tunneled Dialysis Catheters in Patients with Bloodstream Infection
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: antidiabetics]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: autonomy in intellectually disabled young people aged 6 to 21 years]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: axicabtagene ciloleucel for the treatment of relapsed or refractory large B-cell lymphoma]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Cutaquig, preparation of human immunoglobulins, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of newborn blood spot screening for biotinidase deficiency (BIOT)]
2019     Center for Drug Evaluation (CDE) Assessment of the benefits of community day-care facilities for the physically and mentally handicapped
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Localized and disseminated stages of Lyme disease: from diagnosis to treatment, report in support of the diagnosis and treatment decision support tools]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: acute exacerbations of chronic obstructive pulmonary disease (AECOPD)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: urethral discharge]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: effects of assistance dogs and companion animals on persons with autism spectrum disorder or post-traumatic stress disorder]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Esperoct (turoctocog alfa pegol) – Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     NIHR Health Technology Assessment programme Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with multiple sclerosis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: assessing the senior care and services continuum, prospects for measurement development]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated June 2019: palliative care - fever]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards, updated on May 4th 2020 : guide to preventing and treating chemotherapy or radiotherapy-induced nausea and vomiting in adults]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: HemlibraMC (emicizumab) - Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in July 2019: high blood pressure]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in October 2019: lipid-lowering pharmacologic agents]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: indications justifying the use of imaging for diagnosing patients with primary or secondary headache]
2019     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with influenza vaccination
2019     Adelaide Health Technology Assessment (AHTA) Faecal calprotectin testing in patients suspected of inflammatory bowel disease (IBD) presenting to primary care
2019     Adelaide Health Technology Assessment (AHTA) Immunoglobulin for myasthenia gravis
2019     Adelaide Health Technology Assessment (AHTA) Immunoglobulin for acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (HSCT)
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: managing the risk of suicide and self-harm among youths living in rehabilitation centres for young persons with adjustment problems]
2019     NIHR Health Services and Delivery Research programme Exploring the impact of patient experience data in acute NHS hospital trusts in England: using Actor-Network Theory to optimise organisational strategies and practices for improving patients' experiences of care
2019     Health Quality Ontario (HQO) Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: withdrawal management in adult addiction rehabilitation service centres]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the placenta, utility of and indications for the transfer of samples to the anatomical pathology laboratory for analysis]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: post-tick bite antibiotic prophylaxis to prevent Lyme disease, report in support of the knowledge transfer tools, the Québec’s national medical protocol and the collective prescription template]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: mechanisms for accessing local services]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in August 2020: pharmacological treatment of nausea in a person receiving palliative care]
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Gait speed as predictor of frailty]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Organization of care and services for stroke to optimize access to endovascular treatment in Quebec]
2019     NIHR Health Technology Assessment programme Development and preliminary evaluation of an intervention package to support parents of excessively crying infants
2019     NIHR Public Health Research (PHR) programme A multi-centre individual-randomised controlled trial of screening and brief alcohol intervention to prevent risky drinking in young people aged 14-15 in a high school setting (SIPS JR-HIGH)
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: unusual vaginal discharge]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of low-dose computed tomography lung cancer screening]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: portrait of the Quebec adult trauma care network: 2013 – 2016]
2019     NIHR Public Health Research (PHR) programme Improving health, under community supervision, with the support of a Health Trainer: developing and evaluating a pilot randomised controlled trial
2019     NIHR Health Technology Assessment programme Improving the mental health of children and young people with long term conditions: linked evidence syntheses
2019     NIHR Health Technology Assessment programme Clinical and demographic characteristics associated with delay in help-seeking behaviour in patients with Acute Coronary Syndrome
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: setting safety and conditions for success of vaginal birth after cesarean]
2019     Center for Evidence-based Practice (CEP) Intravenous lidocaine for perioperative pain control
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: intensive outpatient services for youths with psychoactive substance use disorders]
2019     Center for Evidence-based Practice (CEP) Levalbuterol vs albuterol for hospitalized patients
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infection: individual patient data meta-analysis of randomised controlled trials
2019     Center for Evidence-based Practice (CEP) Triple-lumen peripherally-inserted central catheters
2019     Center for Evidence-based Practice (CEP) Tip positioning of short-term central venous catheters
2019     NIHR Health Technology Assessment programme Fuelling health equity? The impact of the Winter Fuel Payment on the health of UK households
2019     NIHR Health Technology Assessment programme Minimally invasive autopsy for fetuses and children based on a combination of post-mortem MRI and endoscopic autopsy examination; feasibility study